Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens

Veterinary Microbiology

Volumn 162, Issue 2-4, 2013, Pages 623-630

  Choi, Jun Gu ^a   Kim, Min Chul ^a   Kang, Hyun Mi ^a   Kim, Kwang Il ^a   Lee, Kyu Jun ^a   Park, Choi Kyu ^b   Kwon, Jun Hun ^a   Kim, Jae Hong ^c   Lee, Youn Jeong ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Kyungpook National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

H5N1 highly pathogenic avian influenza; Vaccine; Virus like particle

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; MATRIX PROTEIN; MINERAL OIL; NUCLEOPROTEIN; PROTEIN ANTIBODY; VIRUS HEMAGGLUTININ; VIRUS LIKE PARTICLE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; BACULOVIRUS EXPRESSION SYSTEM; CLADISTICS; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; EMULSION; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; NONHUMAN; SEROCONVERSION; THROAT CULTURE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CHICKENS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; SF9 CELLS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE; VIRAL MATRIX PROTEINS; VIRION;

ANIMALIA; AVES; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 84872491862     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.11.035     Document Type: Article

References (28)

1. Aguilar-Yanez J.M., Portillo-Lara R., Mendoza-Ochoa G.I., Garcia-Echauri S.A., Lopez-Pacheco F., Bulnes-Abundis D., Salgado-Gallegos J., Lara-Mayorga I.M., Webb-Vargas Y., Leon-Angel F.O., Rivero-Aranda R.E., Oropeza-Almazan Y., Ruiz-Palacios G.M., Zertuche-Guerra M.I., DuBois R.M., White S.W., Schultz-Cherry S., Russell C.J., Alvarez M.M. An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One 2010, 5:e11694.
2. Ali A., Avalos R.T., Ponimaskin E., Nayak D.P. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 Proteinprotein. J. Virol. 2000, 74:8709-8719.
3. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M., Ross T.M. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 2008, 3:e1501.
4. Chang G.R.-L., Lai S.-Y., Chang P.-C., Wang M.-Y. Production of immunogenic one-component avian H7-subtype influenza virus-like particles. Process Biochem. 2011, 46:1292-1298.
5. Chen B.J., Leser G.P., Morita E., Lamb R.A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J. Virol. 2007, 81:7111-7123.
6. Chen H. Avian influenza vaccination: the experience in China. Rev. Sci. Tech. 2009, 28:267-274.
7. Ge J., Deng G., Wen Z., Tian G., Wang Y., Shi J., Wang X., Li Y., Hu S., Jiang Y., Yang C., Yu K., Bu Z., Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 2007, 81:150-158.
8. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 2000, 74:11538-11547.
9. Henning J., Henning K.A., Morton J.M., Long N.T., Ha N.T., Vu L.T., Vu P.P., Hoa D.M., Meers J. Highly pathogenic avian influenza (H5N1) in ducks and in-contact chickens in backyard and smallholder commercial duck farms in Viet Nam. Prev. Vet. Med. 2011, 101:229-240.
10. Islam, M.RIslam, M.R., Haque, M.E., Giasuddin, M., Chowdhury, E.H., Samad, M.A., Parvin, R., Nooruzzaman, M., Rahman, M.M., Monoura, P., 2011, New Introduction of Clade 2.3.2.1 Avian influenza virus (H5N1) into Bangladesh. Transbound. Emerg. Dis., doi: 10.1111/j.1865-1682.2011.01297.x.
11. Jiang W.-M., Liu S., Chen J., Hou G.-Y., Li J.-P., Cao Y.-F., Zhuang Q.-Y., Li Y., Huang B.-X., Chen J.-M. Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China during 2007-2009. J. Gen. Virol. 2010, 91:2491-2496.
12. Kayali G., El-Shesheny R., Kutkat M.A., Kandeil A.M., Mostafa A., Ducatez M.F., McKenzie P.P., Govorkova E.A., Nasraa M.H., Webster R.G., Webby R.J., Ali M.A. Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg. Infect. Dis. 2011, 17:2306-2308.
13. Kim H.-R., Park C.-K., Lee Y.-J., Woo G.-H., Lee K.-K., Oem J.-K., Kim S.-H., Jean Y.-H., Bae Y.-C., Yoon S.-S., Roh I.-S., Jeong O.-M., Kim H.-Y., Choi J.-S., Byun J.-W., Song Y.-K., Kwon J.-H., Joo Y.-S. An outbreak of highly pathogenic H5N1 avian influenza in Korea, 2008. Vet. Microbiol. 2010, 141:362-366.
14. Lee C.-W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of mexican lineage H5N2 avian influenza virus. J. Virol. 2004, 78:8372-8381.
15. Lee D.-H., Park J.-K., Lee Y.-N., Song J.-M., Kang S.-M., Lee J.-B., Park S.-Y., Choi I.-S., Song C.-S. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011, 29:4003-4007.
16. Lu H., Khurana S., Verma N., Manischewitz J., King L., Beigel J.H., Golding H. A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells. PLoS One 2011, 6:e17297.
17. Malik Peiris J.S. Avian influenza viruses in humans. Rev. Sci. Tech. 2009, 28:161-173.
18. Prel A., Le Gall-Recule G., Cherbonnel M., Grasland B., Amelot M., Jestin V. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks. Avian Dis. 2007, 51:484-489.
19. Prel A., Le Gall-Recule G., Jestin V. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks. Avian Pathol. 2008, 37:513-520.
20. Pushko P., Tumpey T.M., Bu F., Knell J., Robinson R., Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005, 23:5751-5759.
21. Quan F.-S., Huang C., Compans R.W., Kang S.-M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 2007, 81:3514-3524.
22. Quan F.-S., Vunnava A., Compans R.W., Kang S.-M. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS ONE 2010, 5:e9161.
23. Rasband, W.S. 1997-2011. ImageJ, U.S. National Institute of Health, Bethesda, Maryland, USA. http://imagej.nih.gov/ij/.S.%201997-2011.
24. Shoji Y., Chichester J.A., Jones M., Manceva S.D., Damon E., Mett V., Musiychuk K., Bi H., Farrance C., Shamloul M., Kushnir N., Sharma S., Yusibov V. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum. Vaccines 2011, 7:41-50.
25. Suarez D.L. Overview of avian influenza DIVA test strategies. Biologicals 2005, 33:221-226.
26. Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 2000, 18:1088-1095.
27. Tian G., Zeng X., Li Y., Shi J., Chen H. Protective efficacy of the H5 Inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis. 2010, 54:287-289.
28. WHO/OIE/FAWHO/OIE/FAO H5N1 Evolution Working Group, 2012 Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respi. Viruses 6, 1-5.